ESENDAĞLI, G. Et Al. 2009. Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene. CANCER BIOLOGY & THERAPY , vol.8, no.2 , 136-142.

ESENDAĞLI, G., CANPINAR, H., Yilmaz, G., Gunel-Ozcan, A., Guc, M. O., Kansu, E., ... Guc, D.(2009). Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene. CANCER BIOLOGY & THERAPY , vol.8, no.2, 136-142.

ESENDAĞLI, GÜNEŞ Et Al. "Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene," CANCER BIOLOGY & THERAPY , vol.8, no.2, 136-142, 2009

ESENDAĞLI, GÜNEŞ Et Al. "Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene." CANCER BIOLOGY & THERAPY , vol.8, no.2, pp.136-142, 2009

ESENDAĞLI, G. Et Al. (2009) . "Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene." CANCER BIOLOGY & THERAPY , vol.8, no.2, pp.136-142.

@article{article, author={GÜNEŞ ESENDAĞLI Et Al. }, title={Primary tumor cells obtained from MNU-induced mammary carcinomas show immune heterogeneity which can be modulated by low-efficiency transfection of CD40L gene}, journal={CANCER BIOLOGY & THERAPY}, year=2009, pages={136-142} }